Notas de prensa

Netwrix Security Research Lab Forecasts 2026-2029: The Rise of Identity and Data Security Dependency

Skyhawk Therapeutics Announces Nine Month Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington's Disease

Saber Integrates with Circle Payments Network to Strengthen Global Off-Ramp Capabilities

BrowserStack Launches Accessibility DevTools to Shift Left Accessibility Testing into IDE

DMEGC Solar impulsa la transición a la energía solar del mayor hospital local

Skyhawk Therapeutics anuncia resultados de su ensayo clínico de SKY-0515 para la enfermedad de Huntington

Skyhawk Therapeutics anuncia resultados provisionales de nueve meses en pacientes de su ensayo clínico de fase 1 de SKY-0515 como tratamiento para la enfermedad de Huntington

Capital Gearing Trust P.l.c. - Net Asset Value(s)

Phemex Introduces Elite Trader Recruitment Program Focused on Professional Copy Trading

RoboMarkets expands access to over 1,400 XETRA-traded stocks and ETFs